| Associate Director, Specialty Pharmacy Operations | Madrigal Pharmaceuticals | United States | 2026-07-20 |
| Executive Director, Health Technology | Madrigal Pharmaceuticals | United States | 2026-07-20 |
| Senior Director Biostatistics | Madrigal Pharmaceuticals | United States | 2026-07-20 |
| Principal / Associate Director, Statistical Programming | Madrigal Pharmaceuticals | United States | 2026-07-20 |
| Director, MSAT API Lead | Madrigal Pharmaceuticals | Zug, Switzerland | 2026-07-20 |
| Associate Director, MSAT API | Madrigal Pharmaceuticals | Zug, Switzerland | 2026-07-20 |
| Director, Specialty Pharmacy Operations | Madrigal Pharmaceuticals | United States | 2026-07-20 |
| Senior Director, ADME | Madrigal Pharmaceuticals | United States | 2026-07-20 |
| Associate Director, Study Toxicologist | Madrigal Pharmaceuticals | United States | 2026-07-20 |
| Director of Proposal Writing | Medpace | London, United Kingdom | 2026-07-20 |
| Director, Feasibility | Medpace | London, United Kingdom | 2026-07-20 |
| Director of Feasibility & Proposals | Medpace | Cincinnati, United States | 2026-07-20 |
| Associate Director/Director- Site Contracts | Medpace | Tokyo, Japan | 2026-07-20 |
| Associate Director, Study Start-Up | Medpace | Germany | 2026-07-20 |
| Director - Study Start-Up Project Management | Medpace | Cincinnati, United States | 2026-07-20 |
| Associate Director, Account Management | Medpace | London, United Kingdom | 2026-07-20 |
| Biostatistics Director | Exelixis | Alameda, United States | 2026-07-20 |
| DMPK Director | Exelixis | Alameda, United States | 2026-07-20 |
| Biostatistics Director | Exelixis | Alameda, United States | 2026-07-20 |
| Executive Director, Biostatistics | Exelixis | Alameda, United States | 2026-07-20 |
| Associate Biostatistics Director | Exelixis | Alameda, United States | 2026-07-20 |
| PSC Operations Management Director | Exelixis | Alameda, United States | 2026-07-20 |
| Associate Director, Stability Management | Exelixis | Alameda, United States | 2026-07-20 |
| Executive Director, Scientific Publications (Oncology) | Exelixis | Alameda, United States | 2026-07-20 |
| Sr Director, Biostatistics | Exelixis | Alameda, United States | 2026-07-20 |
| Vice President, Biostatistics | Exelixis | Alameda, United States | 2026-07-20 |
| Executive Director, Biologics Innovation & Strategy | Exelixis | Alameda, United States | 2026-07-20 |
| Director, Omnichannel Analytics | BridgeBio Pharma | San Francisco, United States | 2026-07-20 |
| Senior Director, HEOR โ Acoramidis (Global Lead) | BridgeBio Pharma | San Francisco, United States | 2026-07-20 |
| Associate Director, Biostatistics & AI | BridgeBio Pharma | United States | 2026-07-20 |
| Associate Director, Portfolio Intelligence | BridgeBio Pharma | Palo Alto, United States | 2026-07-20 |
| Associate Director, KOL Engagement (Achondroplasia) | BridgeBio Pharma | United States | 2026-07-20 |
| Senior Director, Market Access Strategy, International | BridgeBio Pharma | Zug, Switzerland | 2026-07-20 |
| Reg Affairs Assoc. Director | BridgeBio Pharma | United States | 2026-07-20 |
| Reg Affairs Director | BridgeBio Pharma | United States | 2026-07-20 |
| Senior/Executive Director, Business Operations | BridgeBio Pharma | San Francisco, United States | 2026-07-20 |
| Associate Director, Field Operations | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-20 |
| Chef.fe d'Agence | Eurofins Scientific | Mamoudzou, Mayotte | 2026-07-20 |
| Responsable de Secteur Hospitalier H/F - Occitanie | Grifols | Paris, France | 2026-07-20 |
| Director, San Diego Technology | Vertex Pharmaceuticals | San Diego, United States | 2026-07-17 |
| Contract & Pricing Strategy Director | Incyte | United States | 2026-07-17 |
| Sr Director, Value & Access | Gilead Sciences | Uxbridge, United Kingdom | 2026-07-17 |
| Global Development Operations Transformation Director | Amgen | United States | 2026-07-17 |
| National Director - Patient Access | Amgen | Thousand Oaks, United States | 2026-07-17 |
| US Strategic Initiatives, Obesity and Related Conditions - Director | Amgen | United States | 2026-07-17 |
| Senior Director, Lab-to-Product Platform and Operations Technology | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-17 |
| Executive Director, Biostatistics | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-17 |
| Associate Director, Global Labeling | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-17 |
| Vice President, Toxicology | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-17 |
| Executive Director, Global Trial Strategy & Operations | Alnylam Pharmaceuticals | Cambridge, United States | 2026-07-17 |